-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The incidence of exacerbated lung disease (PEx) in patients with cystic fibrosis (PwCF) has increased significantly, and the quality of life of these patients will be significantly reduced, and lung function and weight will also be reduced
This study confirmed that the use of 2 IV anti-pseudomonas antibiotics for PEx treatment in young PwCF patients was not associated with greater improvements in measured respiratory and clinical outcomes compared to a single IV anti-pseudomonas antibiotic treatment
Original source:
Jonathan D Cogen.
Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Leave a message here